Skip Navigation LinksHome > Professional Development > eLearning > Case Studies on RhD Genotyping in Pregnancy

Case Studies on RhD Genotyping in Pregnancy

​Please note: AABB reserves the right to make updates to this program.

Wednesday, August 15, 2018
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 18EL-351 (see program format numbers below under Registration)

Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Facilities that perform molecular testing, Hospitals, Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Medical Directors, Physicians, Resident/Fellow, Students (MD, MT, SBB), Technologists
Teaching Level: Intermediate

Director/Moderator: Nancy M. Dunbar, MD, Medical Director, Blood Bank, Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Speaker: Meghan Delaney, DO, MPH, Chief, Pathology & Laboratory Medicine, Children’s National Health System, Washington, DC

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Explain current testing recommendations for management of pregnant women who have serological weak D.
  • Discover how molecular testing can clarify serologic weak D testing results.
  • Examine patient cases where molecular RhD testing guided pregnancy management.

Program Description

Clarification of the underlying genotype of pregnant patients that have weak D phenotypes is important for pregnancy management including need for Rh Immune Globulin prophylaxis and red cell selection, if transfusion is indicated. Current guidelines describe recommendations for the application of molecular RhD testing in this setting. This one-hour case based program will review current recommendations for molecular RhD testing and illustrate how this testing guides the management of pregnant patients with serological weak D.

Registration

   Program #
Single Viewer: Live Register18EL-351-2035
Single Viewer: On-Demand Register18EL-351-4035
Group Viewing: Live Register18EL-351-6035
Group Viewing: On-Demand Register18EL-351-8035
Group Viewing: Live & On-Demand Register18EL-351-9935

Speaker Biography

Dr. Meghan Delaney is the Chief of Pathology & Laboratory Medicine at Children’s National Health System in Washington, DC.  She focuses on pediatric transfusion medicine, the use of RBC genotyping to support patient care, as well as transfusion improvement and sustainable technology development in developing nations. Dr. Delaney chairs or serves on multiple committees for AABB, ASFA, and CAP. She is an Associate Editor for the journal Transfusion Medicine, and is on the editorial board of Transfusion. She is an Associate Scientific Member of the BEST Collaborative.